Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Weight loss drugs are incredibly sought-after, but they’re also often difficult to obtain due to limited insurance coverage ...

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...

A Chicago woman who has struggled with Type 1 diabetes since childhood is now off insulin, thanks to doctors at the ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...

Type 1 diabetes is often confused with Type 2 diabetes, but they are two different diseases. Type 1 diabetes is an autoimmune ...

Tirzepatide, known under the brand name Mounjaro is prescribed for type 2 diabetes, but has been shown in clinical trials to ...